| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |